Brief: MannKind Q1 commercial product sales USD 17.562 million
09/05/2023 22:03
May 9 (Reuters) - MannKind Q1 basic EPS USD -0.04. * Q1 operating income USD -5.998 million * Q1 commercial product sales USD 17.562 million * Q1 net income USD -9.795 million
Recent news on MannKind
See all newsBrief: MannKind Enters Data-Rich Development Period With Completion Of Randomization In Phase 1B Inflo-1 Study And Enrollment Of First Patient In Phase 2 Inflo-2 Trial For Nintedanib Dpi In Patients With Ipf
U.S. STOCKS ON THE MOVE-Dell, Gap, Costco
MannKind rises after FDA approves inhaled insulin for children
US FDA approves MannKind's inhaled insulin for children (updated)
US FDA approves MannKind's inhaled insulin for children